Seelaus Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $324K | Hold |
|
|||||
|
2025
Q2 | $268K | Sell |
|
|||||
|
2025
Q1 | $271K | Sell |
|
|||||
|
2024
Q4 | $330K | Sell |
|
|||||
|
2024
Q3 | $496K | Sell |
|
|||||
|
2024
Q2 | $486K | Buy |
|
|||||
|
2024
Q1 | $475K | Buy |
|
|||||
|
2023
Q4 | $444K | Buy |
|
|||||
|
2023
Q3 | $339K | Sell |
|
|||||
|
2023
Q2 | $426K | Buy |
|
|||||
|
2023
Q1 | $349K | Buy |
|
|||||
|
2022
Q4 | $348K | Buy |
|
|||||
|
2022
Q3 | $312K | Buy |
|
|||||
|
2022
Q2 | $291K | Buy |
|
|||||
|
2022
Q1 | $346K | Sell |
|
|||||
|
2021
Q4 | $717K | Buy |
|
|||||
|
2021
Q3 | $577K | Buy |
|
|||||
|
2021
Q2 | $567K | Buy |
|
|||||
|
2021
Q1 | $453K | Sell |
|
|||||
|
2020
Q4 | $544K | Hold |
|
|||||
|
2020
Q3 | $430K | Hold |
|
|||||
|
2020
Q2 | $432K | Sell |
|
|||||
|
2020
Q1 | $311K | Hold |
|
|||||
|
2019
Q4 | $382K | Sell |
|
|||||
|
2019
Q3 | $311K | Sell |
|
|||||
|
2019
Q2 | $374K | Hold |
|
|||||
|
2019
Q1 | $387K | Hold |
|
|||||
|
2018
Q4 | $306K | Buy |
|
|||||
|
2018
Q3 | $406K | Sell |
|
|||||
|
2018
Q2 | $474K | Sell |
|
|||||
|
2018
Q1 | $485K | Buy |
|
|||||
|
2017
Q4 | $463K | Buy |
|